skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Stonegate Capital put out a favourable update today on Input Capital. They listed details like the market streaming initiative INP launched, noting the 180 new farmers y over y signed up, that this product has much higher margins than their legacy capital streaming contracts. In short Stonegate is endorsing INP. If Input Capital is not looking to raise money thus Stonegate has no opportunity for underwriting business then what motivation would they have for publishing this report... other than taking the report at face value? Should I be looking for bias here?
Read Answer Asked by Harry on January 22, 2018
Q: Can I get your assessment of this company in light of cannacord's recent endorsement as a promising stock for this year (being mindful that it's price jump today has breached the analysts' target price for the year) . Financial Post also noted that iAnthus' inclusion on the upcoming mjna growers index etf may impact its performance to the upside. Your valued thoughts pls
Read Answer Asked by Vicki L on January 19, 2018
Q: Hi team - Happy New Year!
I'm interested in investing in the bioplastics sector because I'm thinking alternatives to plastics that are made out of natural ingredients and plants that are completely compostable and just as effective (if not more) and durable, and similar in cost, as many conventional plastics that are made out of petrochemicals, will be a growing industry (already growing rapidly in the EU).
I have found a publicly listed company on the Venture in GDNP that's a microcap and they make many bioplastic products. Can you tell me your thoughts on this company. I know its not profitable, but revenues have been increasing and they're predicting they will increase by 50% this year. I'm fully aware of how speculative such a small company like this is, but as a highly speculative play where it would make up a small position in a growth portfolio, what do you guys think? And do they have any major competitors or dominant players already in this industry that I'm not aware of? And if so, would you recommend purchasing one of these major companies (assuming they're publicly listed) instead of GDNP?
Hope you're having a great weekend!
Cheers,
Read Answer Asked by Jason on January 16, 2018
Q: Hello 5i team, Walter Capital and management are taking ERG private. While this offer allows shareholders an exit, it seems like a lowball offer (growth will be renewed as they are starting to roll store into superclinics in Quebec, operations have been mostly but marginally profitable over the last few years, cash is about 10¢ per share), and management negotiated to keep their job and shares. (#1) No liquidity in the stock market => low offer?
Even if I think the probability of a competing bid is close to zero, (#2) I would like your opinion on the probability of a competing bid. As ERG is a micro cap and management do not sell (and stays), and the closing ability of the buyer is very good. The deal has been announced few days ago, , and the special meeting of shareholders will be held in the first quarter (after the circular will be mailed). (#2) From the press release, what month (April?) do you think it could close? I am trying to determine whether to hold until closing or sell immediately. 1/2 ¢ = 1,7% return over 4 months? Even if 5i Research is providing great investment ideas, I am in no hurry to reinvest the cash, as I have been building firepower (reducing leverage) during the past year (RDM, TNC, PJC, AF) in order to prepare for a future market wide buying opportunity.
Thank you for your collaboration, Eric
Read Answer Asked by Eric on January 16, 2018
Q: Hi 5i - Where are you at with AT? I'm down 50% and am wondering if you would hold or move on.
Thx
Read Answer Asked by Rick on January 16, 2018
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!